Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Dec 2021 for HARVARD BIOSCIENCE INC, €18k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kenneth Fletcher Olson: trading record in brief
Kenneth Fletcher Olson is a declared insider of Harvard Bioscience Inc (senior executive), with filings sourced from SEC (Form 4). Between 11 June 2021 and 29 December 2021, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 30 December 2021 came the latest disclosure, a share grant for €18k in Harvard Bioscience Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kenneth Fletcher Olson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,812 shares@ US$7.2764.8% of flowCommon StockSEC:0000921895-21-002906:0
1,539 shares@ US$7.3735.2% of flowCommon StockSEC:0000921895-21-002516:0
18,378 shares0Common StockSEC:0000921895-21-001648:0
3 of 3 declarations
